Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization

Fertility and Sterility

Volumn 88, Issue 2, 2007, Pages 350-353

  Keltz, Martin D ^a   Gera, Puja S ^a   Skorupski, Josh ^a   Stein, Daniel E ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

flare protocol; Oral contraceptive pills; poor responders

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; FOLLITROPIN; GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY;

ADULT; CONTRACEPTIVES, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMANS; INFERTILITY, FEMALE; LEUPROLIDE; LUTEINIZING HORMONE; TREATMENT FAILURE;

EID: 34547690888     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.123     Document Type: Article

References (14)

1. Neveu S., Hedon B., Bringer J., Chinchole J.M., Arnal F., Humeau C., et al. Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 47 (1987) 639-643
2. Ben-Rafael Z., Lipitz S., Bider D., and Mashiach S. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril 55 (1991) 272-275
3. Testard J., Lefebvre B., and Gougeon A. Effects of Gonadotropin-releasing hormone agonist (GnRHa) on follicle and oocyte quality. Hum Reprod 8 (1993) 511-518
4. Garcia J.E., Padilla S.L., Bayati J., and Baramki T.A. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in-vitro fertilization. Fertil Steril 53 (1990) 302-305
5. Loumaye E., Vankrieken L., Depreester S., Psalti I., Cooman S.D., and Thomas K. Hormonal changes induced by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryonic development. Fertil Steril 51 (1989) 105-111
6. Gonen Y., Jacobson W., and Casper R.F. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil Steril 53 (1990) 282-287
7. Al-Mizyen E., Sabatini L., Lower A.M., Wilson C.M.Y., Al-Shawaf T., and Grudzinskas J.G. Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?. J Assist Reprod Genet 17 (2000) 140-146
8. Klein T.A., and Mishell D.R. Gonadotropin, prolactin, and steroid hormone levels after discontinuation of oral contraceptives. Am J Obstet Gynecol 127 (1977) 585-589
9. Benadiva C.A., Ben-Rafael Z., Blasco L., Tureck R., Mastroianni Jr. L., and Flickinger G.L. Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives. Fertil Steril 50 (1988) 516-518
10. Biljan M.M., Mahutte N.G., Dean N., Hemmings R., Bissonnette F., and Tan S.L. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 70 (1998) 1063-1069
11. Schoolcraft W., Schlenker M.A., Gee M., Stevens J., and Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 67 (1997) 93-97
12. Gelety T.J., Pearlstone A.C., and Surrey E.S. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women. Fertil Steril 64 (1995) 1074-1080
13. Bo-Abbas Y.Y., Martin K.A., Liberman R.F., Cramer D.W., and Barbieri R.L. Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist. Fertil Steril 75 (2001) 694-699
14. Sims J.A., Seltman H.J., and Muasher S.J. Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization. Hum Reprod 9 (1994) 235-240